Ziopharm Oncology (ZIOP) Gains; Agora Said Positive
- Wall Street opens slightly lower as oil falls
- Boston Scientific (BSX) to Acquire EndoChoice (GI) in ~$210M Deal
- Oil prices slip as hopes for a deal in Algiers fade
- Mexican and Canadian currencies rise, investors feel Clinton won debate
- Pre-Open Stock Movers 09/27: (GI) (KITE) (INFI) Higher; (NAT) (SXL) (RICE) Lower (more...)
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
Ziopharm Oncology (NASDAQ: ZIOP) Gains; Agora Said Positive
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Most SABMiller Proxy Votes Said to Back AB InBev (BUD) Takeover Bid - Bloomberg
- Stocks with Implied Volatility Movement
- Deutsche Bank (DB) Must Solve Its Own Problems, SPD Caucus Leader Oppermann Says - Bloomberg
Create E-mail Alert Related CategoriesTrader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!